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BILIARY DISEASE
A randomised controlled trial of endoscopic
sphincterotomy in acute cholangitis without common bile
duct stones
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Background: Biliary decompression with endoscopic sphincterotomy (EPT) is beneficial in patients
with biliary obstruction due to common bile duct (CBD) stones. However, it is not known whether EPT
with decompression of the bile duct is beneficial in patients with acute cholangitis and gall bladder
stones but without evidence of CBD stones.
Aim: A randomised controlled study to assess the effect of EPT on the outcome of patients suffering from
acute cholangitis with gall bladder stones but with no CBD stones on initial endoscopic retrograde
cholangiopancreatography.
Patients: A total of 111 patients were recruited into the study.
Methods and results: Fifty patients were randomised to receive EPT while 61 patients received no
endoscopic intervention. There was a significant difference in the duration of fever in the EPT and non-
EPT groups (mean (SD): 3.2 (2.2) days v 4.3 (2.1) days; p<0.001). Duration of hospital stay was also
shorter in the EPT group than in the non-EPT group (mean (SD): 8.1 (3.0) v 9.1 (3.2) days; p=0.04).
Patients were followed up for a mean (SD) of 42.4 (11.1) months. Twenty three patients (20.3%) devel-
oped recurrent acute cholangitis (RAC): 14 patients (12.6%) in the EPT group and nine patients (8.1%)
in the non-EPT group (p=0.09).
Conclusion: EPT in patients with acute cholangitis without CBD stones decreased the duration of acute
cholangitis and reduced hospital stay but it did not decrease the incidence of RAC.
Bacterial cholangitis resulting from benign or malignantobstruction is a life threatening disease, especially in theelderly. Approximately 15–30% of patients with acute
cholangitis fail to respond to antibiotic therapy and require
urgent biliary drainage.1
Endoscopic sphincterotomy (EPT) was first used for the
treatment of choledocholithiasis and cholangitis in 1974.2 3
Early results showed that EPT with or without stone extraction
can be an effective treatment for acute cholangitis but is best
avoided in critically ill patients with acute suppurative
cholangitis as repeated biliary manipulation and/or injection of
contrast can increase the chance of cholangiovenous reflux and
worsen the ongoing septicaemia in this group of patients.
The current recommendation is that the initial treatment of
acute cholangitis should consist of intravenous antibiotic
therapy directed against enteric gram negative pathogens
followed by elective endoscopic retrograde cholangiopancrea-
tography (ERCP) for diagnosis and treatment of biliary
obstruction. Patients who do not respond to appropriate
antimicrobial therapy within 24–48 hours should undergo
emergency ERCP for biliary drainage. If possible, the bile duct
should be deeply cannulated and purulent bile aspirated to
decompress the biliary system.4
Biliary decompression with or without EPT is beneficial in
patients with biliary obstruction due to either common bile
duct (CBD) stones or malignant obstruction. However, it is not
known if EPT with decompression of the bile duct is beneficial
in patients with acute cholangitis and gall stones (GB stones)
but without evidence of CBD or intrahepatic stones. Vaira and
colleagues5 suggested that EPT was not necessary in younger
patients because it is possible to provide close surveillance for
such patients. However, for elderly patients follow up is diffi-
cult and missed bile duct stones are associated with increased
morbidity and mortality and so it is their policy to perform an
EPT and trawl the bile duct with a balloon or a basket. To date
there has been no controlled study in this particular group of
patients with acute cholangitis without CBD stones on ERCP.
Therefore, we conducted a randomised controlled study to
assess the effect of EPT on the outcome of patients suffering
from acute cholangitis, with GB stones but no CBD stones on
initial ERCP. The primary aim of the study was to compare the
outcome of patients who received EPT with those who did not.
The secondary aim of this study was to determine if EPT can
prevent the development of recurrent acute cholangitis (RAC)
on long term follow up.
METHODS
Patients admitted to the Department of Medicine, Queen
Mary Hospital for acute cholangitis with GB stones between
1 January 1996 and 31 December 1998 were recruited into the
study. Those with malignant obstruction, intrahepatic chole-
lithiasis, and choledocholithiasis on ERCP were excluded.
Acute cholangitis was defined as the presence of abdominal
pain, fever, jaundice, and dilated CBD on ultrasound (USG).
All patients were commenced on intravenous cefoperazone
after blood cultures were taken. Complete blood counts, elec-
trolytes, clotting profile, and liver function tests were
monitored daily until discharge. Blood pressure and pulse rate
were monitored every hour and temperature was checked
every four hours. ERCP with a side viewing duodenoscope
(Olympus, Tokyo) was performed within 24–48 hours of
admission for all patients. Cefoperazone was switched to
another antibiotic if blood culture showed an organism resist-
ant to cefoperazone.
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ERCP was carried out in the endoscopy room under fluoro-
scopic screening (Philips Diagnost 65). For ERCP, patients
were given a topical pharyngeal spray with 10% lignocaine,
and sedated with intravenous midazolam and pethidine
hydrochloride. Duodenal relaxation was induced with intra-
venous hyoscine butylbromide. Patients were randomised to
receive either EPT or no intervention. The CBD was trawled
with a Dormia-type basket and balloon catheter after EPT to
remove mud and debris in the CBD. Two groups of
endoscopists were responsible for performing all ERCPs. Both
groups had more than five years of experience in performing
ERCP. Patients were randomised to either group according to a
list of random numbers generated by a computer booking sys-
tem. After ERCP, patients were managed by a team of
physician who were blinded to the treatment assignment.
Patients were followed up once every three months in the
first year and then once every six months in the second year.
Thereafter, patients were followed up yearly until the end of
the study, in this case the 30 June 2001. A physical examina-
tion of the abdomen, cardiovascular and respiratory system,
and liver biochemistry were performed for each patient during
every follow up.
The primary outcome of this study was RAC. RAC is defined
as another episode of abdominal pain, fever, and jaundice with
raised alkaline phosphatase and bilirubin levels. The second-
ary outcomes of this study were hospital stay, duration of
fever, and need for inotropic support.
Patients recruited into this study was not referred for a
cholecystectomy as some studies have doubted the role of
cholecystectomy in the prevention of RAC.6–8 This study was
approved by the ethics committee of the Faculty of Medicine
of the University of Hong Kong, and informed consent was
obtained from each patient.
Statistical analysis
All statistical analyses were performed using the Statistical
Program for Social Sciences (SPSS 10.0 for windows, SPSS
Inc., Chicago, Illinois, USA). The Student’s t test (unpaired,
two tailed) was used for single comparison of continuous
data, and the χ2 with Yates’ correction for continuity or Fisher’s
exact test for categorical variables. Differences in outcome,
fever, hospital stay, subsequent need for inotropic support, and
RAC in patients with and without EPT were analysed. An
actuarial analysis of risk factors for RAC during follow up was
performed with Kaplan-Meier curves, and differences ana-
lysed using the log rank test. All statistics were performed on
the intention to treat population which included all patients
recruited into the study initially. Statistical significance was
defined as p<0.05 (two tailed).
RESULTS
During this period, there were 655 patients admitted for acute
cholangitis. Of these, 422 patients (64.4%) had CBD stones, 65
(9.9%) had malignant biliary obstruction, 47 (7.7%) had
unsuccessful cannulation of the CBD, and 10 patients (1.5%)
refused to participate in the study. Therefore, only 111 patients
(16.9%) were included in the study.
Fifty patients (45%) were randomised to receive EPT while
61 patients (55%) received no intervention.Mean ages (SD) of
the EPT and non-EPT groups were 68.9 (14.8) years and 72.3
(12.2) years, respectively. The male to female ratio in the EPT
and non-EPT groups were 27:23 and 32:29, respectively.
Demographic data of the two groups are shown in table 1 and
were comparable. None of the patients had internal stenting
or nasobiliary drain insertion.
There was a significant difference in duration of fever in the
EPT and non-EPT groups (mean (SD): 3.2 (2.2) v 4.3 (2.1)
days; p<0.001). Duration of hospital stay in the EPT group
was also significantly shorter than in the non-EPT group
(mean (SD): 8.1 (3.0) v 9.1 (3.2) days; p=0.04). A higher
number of patients in the EPT group developed a peak in fever
within 24 hours post-ERCP compared with the non-EPT group
(17 (34%) v 9 (14.8%) (p=0.02); odds ratio (OR) 2.98, 95%
confidence interval (CI) 1.19–7.46).
Two patients (4%) in the EPT group developed post-ERCP
complications compared with none in the non-EPT group
(p=0.70). The two complications that developed were
post-ERCP acute pancreatitis and post-EPT bleeding. Both
complications were mild, according to the classification of
Cotton and colleagues.9 There was no difference in the subse-
quent requirement for inotropic support between the EPT and
non-EPT groups (0/50 v 1/61; p=0.55). Mortality rate in the
EPT group was 2% (1/50) while in the non-EPT group it was
1.6% (1/61) (p=0.25).
Patients were followed up in our outpatient clinic for a mean
(SD) of 42.3 (11.1) months. Eleven patients (9.9%) were lost to
follow up. RAC developed in 23 patients (20.7%) with 14
patients (12.6%) in the EPT group and nine (8.1%) in the non-
EPT group (p=0.09, OR 2.25, 95% CI 0.88, 5.75). There was no
difference in the time to development of RAC between the two
groups (p=0.10 by log rank test) (fig 1). Three patients (6%) in
the EPT group developed two episodes of RACwhile in the non-
EPT group two patients (3.3%) developed two episodes of RAC
(p=0.66, OR 1.83, 95% CI 0.29, 11.38). No patient developed
more than two episodes of RAC in the follow up period.
Liver biochemistry, size of CBD, age, and sex were not found
to be associated with the development of RAC (all NS). No
patient in either group developed acute cholecystitis or carci-
noma of the gall bladder.
DISCUSSION
Endoscopic decompression of the biliary system with either
stents or EPT has revolutionised the management of acute
cholangitis.10–12 Endoscopic drainage and decompression have
been shown to be successful in treating 97% of patients with
Table 1 Demographic data for the endoscopic sphincterotomy (EPT) and non-EPT
groups
Variable (normal range) EPT group (n=50) Non-EPT group (n=61) p Value
Age (y) 68.9 (14.8) 72.3 (12.2) 0.19
Sex (M:F) 27:23 32:29 0.51
Albumin (42–54 g/l) 38.8 (7.2) 36.1 (5.5) 0.07
Bilirubin (7–19 µmol/l) 41.8 (32.9) 32.9 (41.1) 0.07
ALP (51–141 U/l) 210.3 (111.2) 198.1 (103.5) 0.56
ALT (6–53 U/l) 190.5 (208.8) 118.1 (164.2) 0.13
AST (15–40 U/l) 138.5 (116.1) 151.4 (266.4) 0.41
GGT (9–62 U/l) 309.9 (385.0) 258.1 (205.1) 0.86
PT (11.3–13.2 s) 12.2 (2.4) 13.2 (16.0) 0.20
APTT (27.6–37.6 s) 30.2 (5.1) 31.7 (10.2) 0.97
Size of CBD (mm) 8.9 (2.6) 9.3 (2.8) 0.58
ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; GGT, gamma glutamyl
transpeptidase; PT, prothrombin time; APTT, activated partial thromboplastin time; CBD, common bile duct.
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calculous cholangitis who do not respond to conservative
treatment, with a mortality rate of only 4.7%.13 But in these
studies 80% of their patients had CBD stones and approxi-
mately 20–30%5 11–13 of patients with acute cholangitis did not
have CBD stones, probably due to spontaneous passage of CBD
stones. The issue of whether or not endoscopic decompression
with EPT is beneficial in patients with acute cholangitis who
do not have CBD stones has not been addressed.
Our study showed that urgent EPT in this group of patient
can shorten the duration of fever and also the duration of
hospitalisation. Shortening of hospital stay can be explained
by the shorter duration of fever in the EPT group allowing
patients in this group to be discharged earlier.
A significant number of patients in the EPT group developed
a peak in fever within 24 hours post-EPT compared with the
control group. However, this was not shown to affect the
outcome nor did it lead to a greater need for inotropic support.
The peak in fever and shortened duration of fever in the EPT
group was probably related to a rapid decrease in biliary endo-
toxaemiawithin 24 hours after biliary decompression, as shown
by Lau and colleagues.14 This release in endotoxins by biliary
decompression probably resulted in a systemic inflammatory
response with a peak in fever within this period. Also, it is this
rapid decrease in both biliary and serum endotoxins that led to
a shortened duration of fever in this group.
EPT did not improve the primary outcome or mortality rate
in this group of patients with acute cholangitis. The mortality
rate in this series was low (approximately 2%). This low mor-
tality rate is in contrast with the reported mortality rate of
4–10% for acute cholangitis.13 15 We believe the difference is
due to the high percentage of patients with CBD stones in
these two previous studies. Whereas in this study all patients
recruited had a dilated CBD, none had a CBD stone on cholan-
giography. Perhaps the prognosis of acute cholangitis in those
without a CBD stone is better than in those with a CBD stone
in situ. Further studies are needed to confirm this observation.
Even though there was no significant difference in
post-ERCP complications between the two groups of patients
(p=0.70), the post-ERCP complication rate in the EPT group
was higher than that in the non-EPT group (4% v 0%). It may
not be advisable to perform an EPT in this specific group of
patients as it does not alter mortality rate or outcome. Even
though EPT can shorten the duration of acute cholangitis and
duration of hospital stay, this has to be balanced by the risk of
post-EPT complications.
EPT did not decrease the incidence of RAC on follow up for
a mean period of 42 months. The development of RAC was not
altered by EPT (p=0.10). The role of EPT in young adults
remains controversial because of concerns of the long term
consequences of EPT, with issues raised about the effect of
chronic bacterial contamination, recurrent stones, and risk of
cancer. Some have argued that by damaging the sphincteric
mechanism, the CBD is more easily contaminated by duodenal
juice. If the duodenum is not sterile, as in most elderly
patients, bacteria can pass from the intestine into the bile
leading to repeated episodes of acute cholangitis.16–18
Our study had several limitations. Firstly, endoscopic USG
was not performed in any patient and we also did not look for
crystals or small stones. Hence small stones may have been
missed. However, we believe it is unlikely that a significant
amount of small stones were missed because the prognosis of
acute cholangitis in patients with small CBD stones is thought
to be much poorer than those without small CBD stones if a
sphincterotomy and clearance of small stones is not per-
formed. Our results showed that the mortality rate and subse-
quent requirement for inotropic support in both the EPT and
non-EPT groups were comparable (1/50 v 1/61 (p=0.25) and
0/50 v 1/61 (p=0.55), respectively).
Secondly, cholecystectomy was not performed in this study
which may affect the long term outcome of these patients.
When this study was designed initially, our only aim was to
define the role of sphincterotomy in this group of patient and
as some studies have also questioned the role of cholecystec-
tomy in the prevention of RAC,6–8 we decided not to perform
cholecystectomy. Whether cholecystectomy can help to
decrease the incidence of RAC in this group of patients is not
known and further randomised trials may be needed to clarify
the role of cholecystectomy in this group of patient.
In conclusion, EPT in patients with acute cholangitis with-
out CBD stones can help to decrease the duration of acute
cholangitis and reduce hospital stay but it does not affect the
outcome of acute cholangitis. As EPT does not decrease the
development RAC it is therefore not routinely recommended
because the short term gains do not justify the increased
complications and perhaps death that may result from unnec-
essary sphincterotomy in the absence of ductal stones.
. . . . . . . . . . . . . . . . . . . . .
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Figure 1 Kaplan-Meier curve showing recurrent acute cholangitis
(RAC) in the sphincterotomy and non-sphincterotomy groups.
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